135 related articles for article (PubMed ID: 34321311)
1. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017.
Ko JY; Hirai AH; Owens PL; Stocks C; Patrick SW
Hosp Pediatr; 2021 Aug; 11(8):902-908. PubMed ID: 34321311
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
Hirai AH; Ko JY; Owens PL; Stocks C; Patrick SW
JAMA; 2021 Jan; 325(2):146-155. PubMed ID: 33433576
[TBL] [Abstract][Full Text] [Related]
3. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis.
Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C
Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458
[TBL] [Abstract][Full Text] [Related]
4. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Administrative Data for Identifying Maternal Opioid Use at Delivery in Florida.
Elmore AL; Salemi JL; Kirby RS; Sappenfield WM; Lowry J; Dixon A; Lake-Burger H; Tanner JP
Matern Child Health J; 2023 Dec; 27(Suppl 1):44-51. PubMed ID: 37199857
[TBL] [Abstract][Full Text] [Related]
6. Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome.
Maalouf FI; Cooper WO; Stratton SM; Dudley JA; Ko J; Banerji A; Patrick SW
Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30514781
[TBL] [Abstract][Full Text] [Related]
7. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017.
Goyal S; Saunders KC; Moore CS; Fillo KT; Ko JY; Manning SE; Shapiro-Mendoza C; Gupta M; Romero L; Coy KC; McDow KB; Keaton AA; Sinatra J; Jones K; Alpren C; Barfield WD; Diop H
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):951-955. PubMed ID: 32701936
[TBL] [Abstract][Full Text] [Related]
8. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.
Patrick SW; Schumacher RE; Benneyworth BD; Krans EE; McAllister JM; Davis MM
JAMA; 2012 May; 307(18):1934-40. PubMed ID: 22546608
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
[TBL] [Abstract][Full Text] [Related]
10. Within-Hospital Concordance of Opioid Exposure Diagnosis Coding in Mothers and Newborns.
Clark RRS; French R; Lorch S; O'Rourke K; Rosenbaum KEF; Lake ET
Hosp Pediatr; 2021 Aug; 11(8):825-833. PubMed ID: 34230061
[TBL] [Abstract][Full Text] [Related]
11. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
12. Impact of the ICD-9-CM to ICD-10-CM transition on the incidence of severe maternal morbidity among delivery hospitalizations in the United States.
Metcalfe A; Sheikh M; Hetherington E
Am J Obstet Gynecol; 2021 Oct; 225(4):422.e1-422.e11. PubMed ID: 33872591
[TBL] [Abstract][Full Text] [Related]
13. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
14. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
[TBL] [Abstract][Full Text] [Related]
15. Trends in Severe Maternal Morbidity in the US Across the Transition to ICD-10-CM/PCS From 2012-2019.
Hirai AH; Owens PL; Reid LD; Vladutiu CJ; Main EK
JAMA Netw Open; 2022 Jul; 5(7):e2222966. PubMed ID: 35900764
[TBL] [Abstract][Full Text] [Related]
16. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
17. Trends in Neonatal Opioid Withdrawal Syndrome and Opioid Exposure Diagnoses Among Infants With Private Health Insurance, 2016-2021: Introduction of the P04.14 ICD-10-CM Code.
Campbell AG; Zhang P; Rosenman MB; Scott E; Wiehe SE
Public Health Rep; 2024; 139(1):88-93. PubMed ID: 37119181
[TBL] [Abstract][Full Text] [Related]
18. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
[TBL] [Abstract][Full Text] [Related]
19. Association Between Neonates With Laryngomalacia and Neonatal Abstinence Syndrome.
Abraham EJ; Danis DO; Levi JR
Ann Otol Rhinol Laryngol; 2022 Sep; 131(9):946-953. PubMed ID: 34595938
[TBL] [Abstract][Full Text] [Related]
20. Hospital Care of Opioid-Exposed Newborns: Clinical and Psychosocial Challenges.
Goyal NK; McAllister J
J Hosp Med; 2020 Oct; 15(10):613-618. PubMed ID: 32118559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
